Clinical Trial Update: Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome [Phase 2]

View source ↗

Summary

This Phase 2 trial compared low-molecular-weight heparin to unfractionated heparin in pregnant women with recurrent abortion due to antiphospholipid syndrome. R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abortion
• Antiphospholipid Syndrome

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Cairo University | Conditions: Recurrent Abortion | Phase 2 | Status: COMPLETED | Results posted: 2011-08-29